review · Neurodegenerative Diseases

Circulating Biomarkers for Alzheimer’s Disease: Unlocking the Diagnostic Potential in Low- and Middle-Income Countries, Focusing on Africa

Luc Nwamekang Belinga
Alfred K. Njamnshi
Gilles Allali
Jeanne Espourteille
Olivier Rouaud
Yembe Wepnyu Njamnshi
Ariole Zafack Zeukang
Kevin Richetin

20246 citationsOpen accessUniversité de Yaoundé I

Abstract

Identifying precise, sensitive, and specific blood biomarkers could contribute to the biological characterization and management of AD in Africa. Such advances promise to improve patient care and pave the way for new regional opportunities in pharmaceutical research and drug trials on the continent for AD.

Research topics

Computational Drug Discovery Methods
Alzheimer's disease research and treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1159/000538623

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.